Commonwealth Equity Services LLC boosted its stake in Agilent Technologies, Inc. (NYSE:A – Free Report) by 13.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 40,337 shares of the medical research company’s stock after purchasing an additional 4,732 shares during the quarter. Commonwealth Equity Services LLC’s holdings in Agilent Technologies were worth $5,489,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors have also added to or reduced their stakes in the company. Core Wealth Advisors LLC bought a new position in Agilent Technologies in the 4th quarter worth about $26,000. Board of the Pension Protection Fund bought a new position in Agilent Technologies in the 4th quarter worth about $27,000. Navalign LLC bought a new position in Agilent Technologies in the 4th quarter worth about $27,000. Entrust Financial LLC bought a new position in Agilent Technologies in the 4th quarter worth about $31,000. Finally, Torren Management LLC bought a new position in Agilent Technologies in the 4th quarter worth about $32,000.
Agilent Technologies Stock Performance
NYSE:A opened at $135.51 on Friday. The business has a 50 day moving average of $118.35 and a 200 day moving average of $128.35. The company has a market capitalization of $38.27 billion, a price-to-earnings ratio of 27.21, a PEG ratio of 2.41 and a beta of 1.26. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $160.27. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62.
Agilent Technologies Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be paid a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 30th. Agilent Technologies’s payout ratio is 20.48%.
Analyst Ratings Changes
A number of analysts have recently issued reports on the company. Wolfe Research reiterated a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Bank of America upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and dropped their price target for the company from $150.00 to $145.00 in a research report on Thursday, May 28th. UBS Group dropped their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. TD Cowen boosted their target price on Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Finally, Weiss Ratings upgraded Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and a consensus target price of $161.71.
Read Our Latest Stock Analysis on Agilent Technologies
About Agilent Technologies
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
See Also
- Five stocks we like better than Agilent Technologies
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
